| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |